244 (Imatinib Mesylate 100 mg)
Pill with imprint 244 is Yellow, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..
Imatinib is used in the treatment of chronic myelogenous leukemia; dermatofibrosarcoma protuberans; acute lymphoblastic leukemia; chronic eosinophilic leukemia; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 244
Imatinib Mesylate
- Imprint
- 244
- Strength
- 100 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Bcr-abl tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 70771-1394
Related Images for "244"
More about imatinib
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 39 Reviews
- Drug class: BCR-ABL tyrosine kinase inhibitors
Consumer resources
- Other brands
- Gleevec
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.